PATH is a global nonprofit dedicated to achieving health equity. With more than 40 years of experience forging multisector partnerships, and with expertise in science, economics, technology, advocacy, and dozens of other specialties, PATH develops and scales up innovative solutions to the world’s most pressing health challenges.

PATH’s Center for Vaccine Innovation and Access (CVIA) spans every stage of the complex process of vaccine research, development, and introduction to make lifesaving vaccines widely available to women, children, and communities across the world. CVIA’s current portfolio encompasses more than two dozen vaccines either in development or already in use to protect against 18 different diseases, including diarrheal disease, malaria, meningitis, pneumonia, polio, and COVID. We work in partnership with national health ministries, pharmaceutical manufacturers, donors, international financing and regulatory organizations, and many others. PATH has led numerous global partnerships, including the award-winning Meningitis Vaccine Project and the Malaria Vaccine Initiative, which helped develop the world’s first malaria vaccine recently recommended by the WHO. PATH’s work on vaccine development and introduction encompasses activities including discovery, preclinical development, clinical research and development, process development and manufacturing, regulatory and vaccine introduction. Over 25 candidates and vaccines are currently in our portfolio in the following disease areas – Malaria, Enteric and Diarrheal Diseases, Polio, Respiratory Tract Infections and Meningitis, HPV and Vector-borne viral diseases (e.g., Japanese Encephalitis, Yellow Fever) – and in the cross-cutting areas of Maternal Immunization and Immunization Systems Strengthening.

PATH is currently recruiting for a SENIOR COMMERCIALIZATION OFFICER to support CVIA project teams with business development, intellectual property, and partnering strategies and negotiation of agreements for new partnerships that will enable CVIA to achieve its goals of developing and delivering lifesaving vaccines that can be made available and affordable to those most in need across the world.

CVIA is structured to best apply our experience and expertise to every aspect of vaccine development and introduction across our broad portfolio of vaccine projects. As part of the Integrated Portfolio and Financial Management function, CVIA’s Commercialization team provides business and intellectual property strategy, partnering, and transactional support to CVIA project teams to advance specific vaccine development projects, which are grouped into three core disease areas: Malaria (MAL), Enteric & Diarrheal Diseases (EDD), and Respiratory Infections & Maternal Immunizations (RIMI). The Commercialization team is responsible for negotiating a wide variety of partnership agreements and providing alliance management and coordination across multiple internal and external parties, with emphasis on forming collaborations that support the PATH mission to make vaccines available in developing countries at a cost that will ensure uptake and sustainability for the public sector.

RESPONSIBILITIES

• Serve as a member of CVIA project teams with a focus on ensuring that partnering, global access, intellectual property, market development, and risk management perspectives are integrated into overall project plans.
• Develop and implement intellectual property, technology transfer, and business strategies for specific vaccine development projects, including long-term development projects and complex multi-partner collaborations.
• Support business negotiations for research collaboration, vaccine development, material transfer, intellectual property license agreements, and other types of agreements in support of CVIA projects with pharmaceutical and biotech companies, developing country vaccine manufacturers, academic institutions, and government agencies.
• Ensure that partnerships with collaborators are structured to support global access objectives of providing access to vaccines for the poorest populations.
• Provide alliance management with key vaccine development partners.
• Work effectively with other Commercialization team members, legal counsel, in-country staff, and external partners to meet project goals.
• Support project teams in development of proposals and donor reporting related to vaccine development activities, global access, intellectual property management and other relevant business matters.

Required Skills Required Experience

• Bachelor’s degree plus a minimum of five to seven years related experience required. MBA or advanced science degree with business development or licensing experience strongly preferred.
• Five to seven years of experience in negotiation of various types of collaboration, development, licensing, technology transfer, and supporting agreements in the pharma/biotech industry and/or academic biomedical research sector required.
• Proven track record of successfully establishing and maintaining successful, long-term partnerships.
• Demonstrated ability to negotiate independently and as part of a team.
• Strong organization skills with ability to successfully handle multiple projects and priorities of a complex nature.
• Experience in vaccine field preferred.
• In-depth understanding of biomedical product development preferred.
• Ability and willingness to travel domestically and internationally up to 20% of the time.
• Must have legal authorization to work in the United States.

REMOTE WORK:

PATH continues to evolve to support our employees during the COVID-19 pandemic. Currently, most of PATH’s US based positions are temporarily 100% remote, within commuting distance to our PATH offices. When PATH transitions more broadly to in-person work, we will operate with a hybrid workplace model. Hybrid employees must reside within commuting distance to one of our PATH offices. PATH’s US offices are in Seattle, WA and Washington, D.C.

COVID-19 VACCINE REQUIREMENT:

PATH has instituted a COVID-19 vaccine mandate for all employees, interns, consultants, and temporary staff based in the United States. Individuals selected for job opportunities in the United States must be fully vaccinated, and show proof of vaccination status, upon hire. Individuals are considered fully vaccinated 2 weeks after their second dose in a 2-dose series, such as Pfizer or Moderna, or 2 weeks after a single-dose vaccine, such as Johnson & Johnson. Individuals with medical issues or sincerely held religious beliefs that prevent them from getting the vaccine may request an exemption from the vaccine requirement.

PATH is dedicated to building an inclusive workforce where diversity is valued.

PATH is an equal opportunity employer. Every qualified applicant will be considered for employment. PATH does not discriminate based on race, color, religion, gender, gender identity or orientation, genetic information, age, national origin, marital status, disability status, political ideology, military or protected veteran status, or any other characteristic protected by applicable federal, state, or local law.